not tagged
gsk
['ovarian', 'gskus']
#asco22 real-world evidence suggests parpi use in 1st line maintenance was associated with longer pfs when compared with active surveillance in patients with advanced #ovariancancer. #sponsoredbygskusma 
Gynecologic Oncologist. Lab focused on ending GYN cancers and training future scientists & physicians.